Social Network
News
June 13 2024, 08:00
In a bizarre TV moment, former Fulton County special prosecutor Nathan Wade paused his CNN interview to speak to his consultant as he was grilled about his affair with D.A. Fani Willis.
June 13 2024, 08:00
A House committee is issuing over a dozen subpoenas to Biden's Cabinet over concerns with Biden's March 2021 executive order related to voting and how the agencies will carry it out.
June 13 2024, 08:00
A pro-family group reacted to a new report finding Trump supporters were far more likely than Biden supporters to say society benefits from family and marriage.
June 13 2024, 08:00
Alex Galvagni, CEO of Age of Learning, began his career in artificial intelligence with NASA in the 1990s. He told Fox News Digital that recent advances in AI are set to improve childhood education.
June 13 2024, 08:00
Lake Powell, the second-largest human-made reservoir in the US, has lost nearly 7% of its potential storage capacity since 1963, when Glen Canyon Dam was built, a new report shows.
June 13 2024, 08:00
As the US attempts to wean itself off its heavy reliance on fossil fuels and shift to cleaner energy sources, many experts are eyeing a promising solution: your neighborhood big-box stores and shopping malls.
June 13 2024, 08:00
Three officials at the Fulton County, Georgia, jail have stepped down amid an investigation into the death of an inmate whose family said was housed in a filthy, bug-infested cell that "was not fit for a diseased animal."
June 13 2024, 08:00
A Tennessee Air National Guardsman is facing charges after applying to be a hitman on a spoof "rent-a-hitman" website, according to the Department of Justice.
June 13 2024, 08:00
The family of a victim and several survivors of a mass shooting at a FedEx facility in Indianapolis filed a lawsuit against companies involved in the manufacturing, marketing and sale of the high capacity magazine used by the gunman who killed 8 people and injured several others in 2021.
June 13 2024, 08:00
An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions.